Limited effectiveness of elexacaftor-tezacaftor-ivacaftor on lung hyperinflation in adults with cystic fibrosis

被引：0
|
作者：
Dhote, Theo [1 ]
Martin, Clemence [1 ]
Regard, Lucile [1 ]
Kanaan, Reem [1 ]
Carlier, Nicolas [1 ]
Honore, Isabelle [1 ]
Fesenbeckh, Johanna [1 ]
Burnet, Esperie [1 ]
Fajac, Isabelle [2 ]
Aubourg, Frederique [2 ]
Perez, Thierry [3 ]
Da Silva, Jennifer [1 ]
Burgel, Pierre-Regis [1 ]
机构：
[1] Cochin Hosp, Assistance Publ Hop Paris, Natl Reference Cyst Fibrosis Ctr, Dept Resp Med, Paris, France
[2] Cochin Hosp, Assistance Publ Hop Paris, Dept Physiol, Paris, France
[3] CHRU Lille, Albert Calmette Hosp, Dept Resp Med, Lille, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.OA2906
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Increased fat mass and obesity risk after elexacaftor-tezacaftor-ivacaftor therapy in young adults with cystic fibrosis
    Sanchez-canete, Ana Merino
    Cardenes, Concepcion Marina Lopez
    Santamaria, Saioa Vicente
    Martinez, Jose Ramon Gutierrez
    Gonzalez, Marta Suarez
    Merino, Maria Alvarez
    Jimenez, David Gonzalez
    FRONTIERS IN NUTRITION, 2024, 11
  • [42] The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis
    Scully, Kevin J.
    Marchetti, Peter
    Sawicki, Gregory S.
    Uluer, Ahmet
    Cernadas, Manuela
    Cagnina, Rebecca E.
    Kennedy, John C.
    Putman, Melissa S.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (02) : 258 - 263
  • [43] Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Advanced Cystic Fibrosis Lung Disease
    Djavid, Amir Reza
    Thompson, Alison E.
    Irace, Alexandria L.
    Gusman, Elen
    Altman, Kimberly
    DiMango, Emily A.
    Keating, Claire L.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (11) : 1924 - 1927
  • [44] EFFECTS OF ELEXACAFTOR/ TEZACAFTOR/ IVACAFTOR ON MARKERS OF LIVER FIBROSIS IN ADULTS WITH CYSTIC FIBROSIS
    Portolese, Olivia
    Bilodeau, Marc
    Castel, Helene
    Willems, Bernard E.
    Huard, Genevieve
    Vincent, Catherine
    Lavoie, Annick
    Hercun, Julian
    HEPATOLOGY, 2023, 78 : S638 - S639
  • [45] Effects of elexacaftor/tezacaftor/ivacaftor on liver fibrosis markers in adults with cystic fibrosis
    Tewkesbury, Daniel H.
    Scott, Jennifer
    Barry, Peter J.
    Bright-Thomas, Rowland J.
    Hanley, Karen Piper
    Athwal, Varinder
    Jones, Andrew M.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (02) : 349 - 353
  • [46] Incidence of transaminitis in adults with cystic fibrosis taking elexacaftor/tezacaftor/ivacaftor
    Wood, Marci
    Babowicz, Faith
    Kennedy, Amanda G.
    Antell, Martine
    Gilhooly, Elizabeth
    Tompkins, Bradley J.
    Reddy, Sheela S.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (03) : 920 - 924
  • [47] Peripheral lung effect of elexacaftor/tezacaftor/ivacaftor in adult cystic fibrosis
    Stylemans, Dimitri
    Darquenne, Chantal
    Schuermans, Daniel
    Verbanck, Sylvia
    Vanderhelst, Eef
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (01) : 160 - 163
  • [48] Elexacaftor/Tezacaftor/Ivacaftor as a Bridge to Lung Retransplant in a Recipient With Cystic Fibrosis
    FitzMaurice, Thomas Simon
    Nazareth, Dilip
    Iyer, Kapil
    Walshaw, Martin
    Al-Aloul, Mohamed
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (04) : 433 - 435
  • [49] CGM patterns in adults with cystic fibrosis-related diabetes before and after elexacaftor-tezacaftor-ivacaftor therapy
    Crow, Hanna
    Bengtson, Charles
    Shi, Xiaosong
    Graves III, Leland
    Anabtawi, Abeer
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2022, 30
  • [50] Elexacaftor-Tezacaftor-Ivacaftor in 2 cystic fibrosis adults homozygous for M1101K with end-stage lung disease
    Leung, Winnie M.
    Davoodi, Parastoo Molla
    Langevin, Ashten
    Smith, Clare
    Parkins, Michael D.
    RESPIRATORY MEDICINE CASE REPORTS, 2023, 46
12345